Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
about
HPV & head and neck cancer: a descriptive updateInterventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapyChemotherapy for nasopharyngeal carcinomaNedaplatin: a cisplatin derivative in cancer chemotherapyPlanned neck dissection following chemo-radiotherapy in advanced HNSCCA non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas.A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.Neoadjuvant chemotherapy in oral cancers: Selecting the right patientsEmerging Treatment Paradigms in Radiation OncologyThe role of systemic treatment before, during, and after definitive treatmentRandomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or ..Status quo and directions in deep head and neck hyperthermiaMicroarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinomaGenome stability pathways in head and neck cancersDecitabine rescues cisplatin resistance in head and neck squamous cell carcinomaPreservation of organ function in head and neck cancer.Functional organ preservation in laryngeal and hypopharyngeal cancer.Recent advances: Radiotherapy.Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancersFractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line.CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma.Curative and organ-preserving treatment with intra-arterial carboplatin induction followed by surgery and/or radiotherapy for advanced head and neck cancer: single-center five-year resultsComparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer.A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservationEarly and long-term morbidity after total laryngopharyngectomy.Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.DNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell linesChemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal CancerMulticenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinomaTreatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities.Conference report on the Indo Global Summit on Head and Neck Oncology (IGSHNO 2017-BMCON-IV), 24-26 February 2017, Jaipur, India.Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study
P2860
Q21198763-09F521DE-F05A-44F1-BF1D-A1A496A6A695Q24235245-2E56C9F8-9E0F-4914-8605-5E3AC15EF863Q24250146-2EDEDB0C-56D9-4128-984D-8368373693C2Q24623561-7A9056DC-0EBE-4368-9536-1299FF27BC1EQ24796568-8D4C5D45-36D9-4CE6-87AB-C818514E62DAQ25255201-7965518F-BCE9-45C4-BF07-FF4482028AE7Q25255831-50FCB7AA-DBED-4013-8F53-453677E6E6AEQ26768434-49548295-FDD9-430A-8FC6-FF269D7ACCFFQ26853461-1F98FD98-272C-4EE8-88E0-4F3B80587873Q26859285-CF79FF2A-31BA-423F-A5F8-2F845D0F2D9EQ27313572-4AC82CFB-A83D-4529-890D-93C7643EC201Q27853302-803454C7-1D5E-45FB-8106-55F129E38EF5Q28078795-B77F064E-C7EC-444F-AC71-5E6E6485BAA2Q28116304-C1807EE4-1A21-4EEA-9824-61CD1AD0C2E7Q28391355-4CA1C6FA-3DE0-4C0C-95E8-05AFE8E584FAQ28544907-C73381A5-6543-44F4-8E99-CCDD1F11D102Q30459136-618A1D68-F3F7-402D-9868-4488BA5B46FEQ30467853-33D4E85D-C11E-4D70-B345-E146170D4D7FQ30498493-B319A60D-3B84-4849-8647-5E4FEB44D046Q30579903-1CB54A7E-EDBF-48CD-9DC6-5DB706D7A736Q30666523-E4962E2E-5736-428D-87A0-EA9C260AB9C8Q30823476-EA1E709F-6151-481A-90DD-4E0AB66C461CQ31040425-A20224A8-FD71-404E-BBD2-7FCAE9F83E35Q33281828-05FC7D3F-D198-4263-8695-9D3B6F1B0528Q33321973-E107EDF8-9260-4A64-AD5B-E2FC17636405Q33335940-ECE4BF38-058F-4FAD-8A34-F1769CD806C2Q33380006-117F68EB-0AB0-40BE-8BFA-D78AA6EA73F0Q33386187-C0EB9A9F-563F-4BA4-A201-D32F8F393B3BQ33491298-3A4C69BA-4ADF-47D0-B0E5-776F954FE9EAQ33542810-F924FB22-C2B8-4D7C-958E-4070F6287130Q33550390-68319C88-3B00-4917-8FAA-CCDDD50CC15FQ33561959-06ABE33B-FA6D-4A8A-BD50-803EC255B93DQ33570512-A1C5B5D7-5A71-4828-B344-7511AC9C13D2Q33582958-607517FC-83BF-4410-86FD-0B43479A0E19Q33590769-64E13E7C-39CA-47EB-A19C-BB4F54906D16Q33711438-ADAA641E-4791-4013-8F02-EE5E1D232F90Q33724272-46278385-FA50-4A6A-8692-ED2BFBA6FE00Q33746533-E4AFB385-7EEE-4487-965C-6AABD71F2606Q33778434-1E5182BA-C6B7-476A-92BF-05D693E9BF91Q33795763-8C8C1090-6596-481D-8E8A-20E759125EF2
P2860
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chemotherapy added to locoregi ...... erapy on Head and Neck Cancer.
@ast
Chemotherapy added to locoregi ...... erapy on Head and Neck Cancer.
@en
type
label
Chemotherapy added to locoregi ...... erapy on Head and Neck Cancer.
@ast
Chemotherapy added to locoregi ...... erapy on Head and Neck Cancer.
@en
prefLabel
Chemotherapy added to locoregi ...... erapy on Head and Neck Cancer.
@ast
Chemotherapy added to locoregi ...... erapy on Head and Neck Cancer.
@en
P2093
P921
P1433
P1476
Chemotherapy added to locoregi ...... herapy on Head and Neck Cancer
@en
P2093
P304
P356
10.1016/S0140-6736(00)90011-0
P407
P577
2000-03-01T00:00:00Z